Spinal cord MRI in multiple sclerosis-diagnostic, prognostic and clinical value

Nature Reviews Neurology

Volumn 11, Issue 6, 2015, Pages 327-338

  Kearney, Hugh ^a   Miller, David H ^a   Ciccarelli, Olga ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ATROPHY; CELL ACTIVITY; CLINICAL PRACTICE; DEMYELINATING DISEASE; DEMYELINATION; DIAGNOSTIC VALUE; DISEASE MARKER; GRAY MATTER; GREY MATTER ATROPHY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; METABOLITE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROANATOMY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPINE RADIOGRAPHY; DISEASE COURSE; NEUROMYELITIS OPTICA; PATHOLOGY; PROCEDURES; SPINAL CORD;

DISEASE PROGRESSION; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PROGNOSIS; SPINAL CORD;

EID: 84930570719     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.80     Document Type: Review

References (126)

1. Kidd, D. et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43, 2632-2637 (1993).
2. McDonald, I. & Compston, A. McAlpine's Multiple Sclerosis 287-342 (Elsevier, 2006).
3. Bot, J. C. et al. Spinal cord abnormalities in recently diagnosed MS patients. Added value of spinal MRI examination. Neurology 62, 226-233 (2004).
4. Lycklamaà Nijeholt, G. J. et al. Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 121, 687-697 (1998).
5. Barkhof, F. The clinico-radiological paradox in multiple sclerosis revisited. Curr. Opin. Neurol. 15, 239-245 (2002).
6. Bergers, E. et al. Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 59, 1766-1771 (2002).
7. Bergers, E. et al. Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology. Ann. Neurol. 51, 652-656 (2002).
8. Weier, K. et al. Biplanar MRI for the assessment of the spinal cord in multiple sclerosis. Mult. Scler. 18, 1560-1569 (2012).
9. Stroman, P. W. et al. The current state-of-the-art of spinal cord imaging: methods. Neuroimage 84, 1070-1081 (2014).
10. Losseff, N. A. et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119, 701-708 (1996).
11. Kremenchutzky, M., Rice, G. P., Baskerville, J., Wingerchuck, D. M. & Ebers, G. C. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 129, 584-594 (2006).
12. Kalkers, N. F., Barkhof, F., Bergers E, van Schijndel, R. & Polman, C. H. The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Mult. Scler. 8, 532-533 (2002).
13. Wheeler-Kingshott, C. A. et al. The current state-of-the-art of spinal cord imaging: applications. Neuroimage 84, 1082-1093 (2014).
14. Oh, J. et al. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis. Mult. Scler. 19, 427-435 (2013).
15. Zackowski, K. M. et al. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetisation transfer-imaging abnormalities in the spinal cord. Brain 132, 1200-1209 (2009).
16. Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: revisions to the McDonald criteria. Ann. Neurol. 69, 292-302 (2011).
17. Thorpe, J. W. et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing remitting multiple sclerosis. Neurology 46, 373-378 (1996).
18. O'Riordan, J. I. et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem and spinal cord syndromes suggestive of demyelination. J. Neurol. Neurosurg. Psychiatry 64, 353-357 (1998).
19. Miller, D. H. et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult. Scler. 14, 1157-1174 (2008).
20. Bot, J. C. et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223, 46-56 (2002).
21. Barkhof, F. Spinal cord MRI should always be performed in clinically isolated syndrome patients: yes. Mult. Scler. 20, 1688-1689 (2014).
22. Rovira, A. & Tintoré, M. Spinal cord MRI should always be performed in clinically isolated syndrome patients: no. Mult. Scler. 20, 1686-1687 (2014).
23. Theodoridou, A. & Settas, L. Demyelination in rheumatic diseases. J. Neurol. Neurosurg. Psychiatry 77, 290-295 (2006).
24. Lycklamaà Nijeholt, G. J. et al. Post-mortem high resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 124, 154-166 (2001).
25. Seewann, A. et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch. Neurol. 66, 601-609 (2009).
26. Wingerchuk, D. M. et al. The spectrum of neuromyelitis optica. Lancet Neurol. 6, 805-815 (2007).
27. Wingerchuk, D. M. et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485-1489 (2006).
28. Flanagan, E. P. et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 72, 81-87 (2015).
29. Lennon, V. A. et al. A serum antibody marker of neuromyelitis optica. Lancet 364, 2106-2112 (2004).
30. Kim, H. J. et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84, 1165-1173 (2015).
31. Liu, Y. et al. Differential patterns of spinal cord and brain atrophy in NMO and MS. Neurology 84, 1465-1472 (2015).
32. Yonezu, T. et al. "Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult. Scler. 20, 331-337 (2014).
33. Kearney, H., Miszkiel, K. A., Yiannakas, M. C., Ciccarelli, O. & Miller, D. H. A pilot study of white and grey matter involvement by multiple sclerosis spinal cord lesions. Mult. Scler. Relat. Disord. 2, 103-108 (2013).
34. Sombekke, M. H. et al. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80, 69-75 (2013).
35. Swanton, J. K. et al. Early MRI in optic neuritis: the risk for disability. Neurology 72, 542-550 (2009).
36. Perumal, J. et al. Acute transverse myelitis with normal brain MRI: long-term risk of MS. J. Neurol. 255, 89-93 (2008).
37. Cordonnier, C. et al. Prospective study of patients presenting with acute partial transverse myelopathy. J. Neurol. 250, 1447-1452 (2003).
38. Sastre-Garriga, J. et al. Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data. Neurology 65, 633-635 (2005).
39. Fog, T. Topographical distribution of plaques in the spinal cord of multiple sclerosis. Arch. Neurol. Psychiatry 63, 382-414 (1950).
40. Oppenheimer, D. R. The cervical cord in multiple sclerosis. Neuropathol. Appl. Neurobiol. 4, 151-162 (1978).
41. White, M. L., Zhang, Y. & Healey, K. Cervical spinal cord multiple sclerosis: evaluation with 2D multi-echo recombined gradient echo MR imaging. J. Spinal Cord Med. 34, 93-98 (2011).
42. Ozturk, A. et al. Axial 3D gradient-echo imagingfor improved multiple sclerosis lesion detection in the cervical spinal cord at 3 T. Neuroradiology 55, 431-439 (2013).
43. Nair, G., Absinta, M. & Reich, D. S. Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3 T. AJNR Am. J. Neuroradiol. 34, 2215-2222 (2013).
44. Poonawalla, A. H., Hou, P., Nelson, F., Wolinski, J. S. & Narayana, P. A. Cervical spinal cord lesions in multiple sclerosis: T1-weighted inversion-recovery MR imaging with phase-sensitive reconstruction. Radiology 246, 258-264 (2008).
45. Philpott, C. & Brotchie, P. Comparison of MRI sequences for evaluation of multiple sclerosis of the cervical spinal cord at 3 T. Eur. J. Radiol. 80, 780-785 (2011).
46. Calabrese, M. et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 64, 1416-1422 (2007).
47. Riederer, I. et al. Double inversion recovery sequence of the cervical spinal cord in multiple sclerosis and related inflammatory diseases. AJNR Am. J. Neuroradiol. 36, 219-225 (2014).
48. Bot, J. C. et al. Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis. Eur. Radiol. 10, 753-758 (2000).
49. Sethi, V. et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J. Neurol. Neurosurg. Psychiatry 83, 877-882 (2012).
50. Kearney, H. et al. Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology 84, 367-373 (2015).
51. Gilmore, C. P. et al. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging. Mult. Scler. 15, 180-188 (2009).
52. Gilmore, C. P. et al. Spinal cord gray matter demyelination in multiple sclerosis: a novel pattern of residual plaque morphology. Brain Pathol. 16, 202-208 (2006).
53. Lovas, G., Szilágyi, N., Majtényi, K., Palkovits, M. & Komoly, S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123, 308-317 (2000).
54. Ganter, P., Prince, C. & Esiri, M. M. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol. Appl. Neurobiol. 25, 459-467 (1999).
55. Evangelou, N., DeLuca, G. C., Owens, T. & Esiri, M. M. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 128, 29-34 (2005).
56. Bot, J. C. et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 233, 531-540 (2004).
57. Daams, M. et al. Mean upper cervical cord area (MUCCA) measurement in long standing multiple sclerosis: relation to brain findings and clinical disability. Mult. Scler. 20, 1860-1865 (2014).
58. Kearney, H. et al. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult. Scler. 20, 72-80 (2014).
59. Oh, J. et al. Spinal cord normalization in multiple sclerosis. J. Neuroimaging 24, 577-584 (2014).
60. Healy, B. C. et al. Approaches to normalization of spinal cord volume: application to multiple sclerosis. J. Neuroimaging 22, e12-e19 (2012).
61. Biberacher, V. et al. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis. Mult. Scler. http://dx.doi.org/10.1177/1352458514546514.
62. Lukas, C. et al. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 86, 410-418 (2015).
63. De Stefano, N. et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 74, 1868-1876 (2010).
64. Kapoor, R. et al. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol. 9, 681-688 (2010).
65. Chataway, J. et al. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 383, 2213-2221 (2014).
66. Lin, X., Tench, C. R., Turner, B., Blumhardt, L. D. & Constantinescu, C. S. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon-1a (Rebif) treatment trial. J. Neurol. Neurosurg. Psychiatry 74, 1090-1094 (2003).
67. Gilmore, C. P. et al. Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol. 19, 642-649 (2009).
68. Schlaeger, R. et al. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann. Neurol. 76, 568-580 (2014).
69. Tench, C. R., Morgan, P. S. & Constantinescu, C. S. Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J. Magn. Reson. Imaging 18, 368-371 (2003).
70. Horsfield, M. A. et al. Rapid semi-automatic segmentation of the spinal cord from the magnetic resonance images: application in multiple sclerosis. Neuroimage 50, 446-455 (2010).
71. Kearney, H. et al. Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J. Magn. Reson. Imaging. 39, 617-623 (2014).
72. Rocca, M. A. et al. A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology 76, 2096-2102 (2011).
73. Liptak, Z. et al. Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis. AJNR Am. J. Neuroradiol. 29, 1465-1470 (2008).
74. Zheng, L. et al. Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis. Mult. Scler. Relat. Disord. 4, 52-57 (2015).
75. Valsasina, P. et al. Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. Radiology 266, 853-861 (2013).
76. Liu, W. et al. In vivo imaging of spinal cord atrophy in neuroinflammatory diseases. Ann. Neurol. 76, 370-378 (2014).
77. Rocca, M. A. et al. Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes. J. Neurol. Neurosurg. Psychiatry 84, 35-41 (2013).
78. Evangelou, N., DeLuca, G. C., Owens, T. & Esiri, M. M. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 128, 29-34 (2005).
79. Androdias, G. et al. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann. Neurol. 68, 465-476 (2010).
80. DeLuca, G. C. et al. Casting a light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology. Brain 136, 1025-1034 (2013).
81. Dousset, V. et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182, 483-491 (1992).
82. Mottershead, J. P. et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis-a post-mortem study of the spinal cord. J. Neurol. 250, 1293-1301 (2003).
83. Bozzali, M. et al. Magnetization-transfer histogram analysis of the cervical cord in patients with multiple sclerosis. AJNR Am. J. Neuroradiol. 20, 1803-1808 (1999).
84. Filippi, M. et al. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 54, 207-213 (2000).
85. Charil, A. et al. Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study. Mult. Scler. 12, 662-665 (2006).
86. Rovaris, M. et al. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J. Neurol. Neurosurg. Psychiatry 69, 723-727 (2000).
87. Rovaris, M. et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124, 2540-2549 (2001).
88. Agosta, F., Pagani, E., Caputo, D. & Filippi, M. Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis. Arch. Neurol. 64, 1302-1305 (2007).
89. Kearney, H. et al. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord. Brain 137, 2456-2468 (2014).
90. Le Bihan, D., Turner, R., Pekar, J. & Moonen, C. T. Diffusion and perfusion imaging by gradient sensitisation: design, strategy and significance. J. Magn. Reson. Imaging 1, 7-28 (1991).
91. Wilm, B. J. et al. Reduced field-of-view MRI using outer volume suppression for spinal cord diffusion imaging. Magn. Reson. Med. 57, 625-630 (2007).
92. Zollinger, L. V. et al. Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. J. Magn. Reson. Imaging 33, 557-564 (2011).
93. Klawiter, E. C. et al. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage. 55, 1454-1460 (2011).
94. Oh, J. et al. Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology 80, 540-547 (2013).
95. Valsasina, P. et al. Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients. Neuroimage 26, 822-828 (2005).
96. Benedetti, B. et al. A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J. Neurol. Neurosurg. Psychiatry 81, 26-30 (2010).
97. Agosta, F. et al. Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI. Neurology 64, 631-635 (2005).
98. Agosta, F. et al. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 130, 2211-2219 (2007).
99. Theaúdin, M. et al. Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study. Neuroradiology 54, 1171-1178 (2012).
100. Freund, P. et al. Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity. Mult. Scler. 16, 1193-1202 (2010).
101. Hesseltine, S. M. et al. Diffusion tensor imaging in multiple sclerosis: assessment of regional differences in the axial plane within normal-appearing cervical spinal cord. AJNR Am. J. Neuroradiol. 27, 1189-1193 (2006).
102. Naismith, R. T. et al. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology 80, 2201-2209 (2013).
103. Kearney, H. et al. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry http://dx.doi.org/10.1136/jnnp-2014-308241.
104. Toosy, A. T. et al. Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis. Neurology 83, 1321-1325 (2014).
105. Kendi, A. T., Tan, F. U., Kendi, M., Huvaj, S. & Tellioglu, S. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46, 764-769 (2004).
106. Bjartmar, C., Kidd, G., Mörk, S., Rudick, R. & Trapp, B. D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48, 893-901 (2000).
107. Blamire, A. M., Cader, S., Lee, M., Palace, J. & Matthews, P. M. Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn. Reson. Med. 58, 880-885 (2007).
108. Ciccarelli, O. et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 130, 2220-2231 (2007).
109. Ciccarelli, O. et al. Spinal cord repair in MS: does mitochondrial metabolism play a role Neurology 74, 721-727 (2010).
110. Bellenberg, B. et al. 1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis. Eur. Radiol. 23, 3379-3392 (2013).
111. Ciccarelli, O. et al. Low myo-inositol indicating astrocytic damage in case series of neuromyelitis optica. Ann. Neurol. 74, 301-305 (2013).
112. Bates, S. E. et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7, 1397-1400 (1996).
113. Solanky, B. S. et al. In vivo magnetic resonance spectroscopy detection of combined glutamate-glutamine in healthy upper cervical cord at 3 T. NMR Biomed. 26, 357-366 (2013).
114. Abdel-Aziz, K. et al. Age related changes in metabolite concentrations in the normal spinal cord. PLoS ONE 9, e105774 (2014).
115. Abdel-Aziz, K. et al. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Brain http://dx.doi.org/10.1093/brain/awv086.
116. Castillo, M., Smith, J. K. & Kwock, L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am. J. Neuroradiol. 21, 1645-1649 (2000).
117. Ciccarelli, O. et al. Assessing neuronal metabolism in vivo by modeling imaging measures. J. Neurosci. 30, 15030-15033 (2010).
118. Agosta, F., Valsasina, P., Caputo, D., Stroman, P. W. & Filippi, M. Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis. Neuroimage 39, 1542-1548 (2008).
119. Agosta, F. et al. Evidence for enhanced functional activity of cervical cord in relapsing multiple sclerosis. Magn. Reson. Med. 59, 1035-1042 (2008).
120. Agosta, F. et al. Primary progressive multiple sclerosis: tactile-associated functional MR activity in the cervical spinal cord. Radiology 253, 209-215 (2009).
121. Valsasina, P. et al. Cervical cord functional MRI changes in relapse-onset MS patients. J. Neurol. Neurosurg. Psychiatry 81, 405-408 (2010).
122. Valsasina, P. et al. Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis. Hum. Brain Mapp. 33, 2072-2080 (2012).
123. Rocca, M. A. et al. Abnormal cervical cord function contributes to fatigue in multiple sclerosis. Mult. Scler. 18, 1552-1559 (2012).
124. Schmierer, K. et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage. 35, 467-477 (2007).
125. Budde, M. D. et al. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed. 21, 589-597 (2008).
126. Stroman, P. W., Tomanek, B., Krause, V., Frankenstein, U. N. & Malisza, K. L. Functional magnetic resonance imaging of the human brain based on signal enhancement by extravascular protons (SEEP fMRI). Magn. Reson. Med. 49, 433-439 (2003).